We recently added Ely Lilly (LLY) to client accounts that employ Northlake’s individual stock strategy. LLY fits the profile we have been looking for to add to the widely held stock portfolio: blue chip financial strength, above-average long-term growth with a reasonable valuation, and diversification from consumer discretionary and consumer technology. We believe LLY can […]
Apple (AAPL): AAPL reported inline results for the company’s 2Q25. Management noted little impact from tariffs, which is no surprise given the bulk of the tariff challenges emanate from the April 2nd announcement. In 2Q25, revenue grew 5%, operating income grew 6%, and EPS grew 8%. These modest growth rates are where AAPL sits now […]
IBM (IBM): IBM reported better than expected 1Q25 results and maintained guidance for 2025. However, the mix of underlying datapoints disappointed investors and the shares are trading down more than 5%. We think the decline is overdone and partially related to the excellent performance of IBM over the past 12 months. Expectations were elevated and […]
Northlake’s Style model is recommending Growth again after two months with a neutral signal. The model is picking up on risks to the economic outlook caused by the chaotic implantation of large tariffs on friends and foes alike. Soft data based on surveys of businesses and consumers already reflect heightened recession risk. Economic data releases […]
Office
20 N 3rd Street
Bayfield, WI 54814
Mail
PO Box 1165
Bayfield, WI 54814
tim@northlakecapital.com
847-226-9713
